Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gabriele Anether"'
Publikováno v:
Journal of Leukocyte Biology. 74:311-330
In the past decade, it was concluded from a number of investigations that death domain-containing members of the tumor necrosis factor-receptor (TNF-R) family and their ligands such as Fas/FasL and TNF-related apoptosis-inducing ligand (TRAIL)-R/TRAI
Publikováno v:
Blood. 101:4561-4568
Tetrocarcin-A (TC-A), an antibiotic agent isolated from actinomycetes, has recently been described to antagonize Bcl-2 functions, thereby sensitizing tumor cells to cell death signals under control of Bcl-2. In this study, we analyzed the direct proa
Autor:
Kristian Pfaller, David Bernhard, Monika Senfter, Gabriele Anether, Richard Greil, Inge Tinhofer, Mitsunobu Hara
Publikováno v:
The FASEB Journal. 16:1295-1297
SPECIFIC AIMSCytotoxic agents frequently fail to induce apoptosis in neoplasias because tumor cells express increased levels of anti-apoptotic proteins, have down-regulated important executor molec...
Publikováno v:
Critical reviews in immunology. 23(4)
During the last decade, the concerted effort of numerous scientific groups has expanded our understanding of the finely tuned network present within bone marrow for the regulation of the hematopoietic system. This network, comprising humoral and cell
Autor:
Inge, Tinhofer, Gabriele, Anether, Monika, Senfter, Kristian, Pfaller, David, Bernhard, Mitsunobu, Hara, Richard, Greil
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 16(10)
The T-ALL cell lines CCRF-CEM and Jurkat were studied for their sensitivity toward apoptosis induced by tetrocarcin-A (TC-A), an antibacterial and antitumor agent isolated from the actinomycete Micromonospora. This substance promoted cell death via a
Publikováno v:
Blood. 99(2)
In their work recently published in Blood , Wierda and coworkers[1][1] demonstrated that adenovirus-mediated gene transfer of CD154 into chronic lymphocytic leukemia (CLL) B cells and the retransfer of these cells into the bloodstream of CLL patients